Request Demo
Last update 08 May 2025
cPLA2α x H1 receptor x GR
Last update 08 May 2025
Basic Info
Related Targets |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
ChiCTR2500098648
Effect of azelastine fluticasone nasal spray on nasal function and symptoms of moderate to severe allergic rhinitis
TCTR20230729001
Efficacy of As-needed versus Regular Use of MP-AzeFlu in Moderate-to-severe Allergic Rhinitis: A randomized controlled trial
NCT06180083
Single Dose Bioequivalence Study of Azelastine Hydrochloride/Fluticasone Propionate 137microgram/50 Microgram Nasal Spray and DYMISTA Nasal Spray in Healthy Adult Human Subjects
100 Clinical Results associated with cPLA2α x H1 receptor x GR
Login to view more data
100 Translational Medicine associated with cPLA2α x H1 receptor x GR
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free